Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Aspen Pharmacare Holdings Limited
LDZAAspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa. Address: Aspen Place, Durban, South Africa
Analytics
Zielpreis von Wall Street
–KGV
17.3214Dividendenrendite
1.88 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen LDZA
Dividenden-Analyse LDZA
Dividendenwachstum über 5 Jahre
9 %Kontinuierliches Wachstum
2 JahreAusschüttungsquote 5-Jahres-Durchschnitt
10 %Verlauf der Dividende LDZA
Bewertung der Aktie LDZA
Finanzen LDZA
Ergebnisse | 2019 | Dynamik |